Market Access Lead METAP & CIS

Primary Purpose

The primary purpose of this role is to provide Market Access, Pricing and Health Care System dynamics input into portfolio expansion business cases as well as to support development of the Global brands value proposition in cross functional alignment with other departments. Further, the role will develop global market access strategy for priority Global launch brands and coordinate with Global Pricing prior to launch to define Global Pricing Guidance for Global and multi-country brands.

Domain 1: Portfolio Expansion

• Provide Global Market Access input for portfolio decisions at the Innovation Board.
• Assess product value by analyzing:
  • Unmet medical need and payer attractiveness.
  • Differentiation vs. alternatives.
  • Access dynamics and willingness-to-pay scenarios.
• Deliverables include:
  • Formulary listing conditions.
  • Pricing assumptions (net selling price, WAC, end-customer price) and risk documentation.
  • Revenue timing assumptions based on country-specific P&R timelines.
  • Guidance on evidence needs and customer research requirements.

Domain 2: Global Product Launch

• Co-develop global market access and pricing strategy with relevant directors.
• Project manage HEOR evidence development for reimbursement and value capture.
• Define global pricing guidance and develop collateral for country teams.
• Monitor and update pricing/revenue assumptions; escalate deviations.
• Educate NPI teams on market access monitoring and escalation protocols.

Additional Responsibilities

• Support strategic initiatives such as:
  • Launch toolkits and portfolio strategy.
  • Country-level market access organization development.
  • Data analytics tool (DART) enhancement.
  • Maintain and audit country system information.
  • Educate EPD global teams on market access and pricing trends.

Minimum Experience

• 6+ years in pharmaceutical market access & pricing consulting or 7+ years in innovative pharma (market access or related functions: BD, Marketing, Medical).
• Strong knowledge of payer relations, pricing, health economics, and policy.
• Proven success in market access, strategic planning, and portfolio evaluation.
• Experience across diverse market archetypes (reimbursed to cash-pay).
• Expertise in biologics/biosimilars access, pricing, HEOR, and institutional/tender business; ability to translate global strategy into local execution.
• Background in matrix organizations and emerging markets (BRIC, SE Asia, LATAM, MENA).
• Strategic consultancy experience preferred.
• Track record in cross-country pricing alignment, approvals, and biologics/biosimilars launches.